These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 6294894)
21. Production of biological active murine IFN-gamma by recombinant Lactococcus lactis. Bermúdez-Humarán LG; Cortes-Perez NG; L'Haridon R; Langella P FEMS Microbiol Lett; 2008 Mar; 280(2):144-9. PubMed ID: 18248432 [TBL] [Abstract][Full Text] [Related]
22. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Diamond MS; Harris E Virology; 2001 Oct; 289(2):297-311. PubMed ID: 11689052 [TBL] [Abstract][Full Text] [Related]
23. Influence of acute and chronic ethanol treatment on interferon production in mice. Daniluk J; Kandefer-Szerszeń M Arch Immunol Ther Exp (Warsz); 1994; 42(3):239-46. PubMed ID: 7487360 [TBL] [Abstract][Full Text] [Related]
24. Chicken interferon types I and II enhance synergistically the antiviral state and nitric oxide secretion. Sekellick MJ; Lowenthal JW; O'Neil TE; Marcus PI J Interferon Cytokine Res; 1998 Jun; 18(6):407-14. PubMed ID: 9660248 [TBL] [Abstract][Full Text] [Related]
25. Activation of human monocyte cytotoxicity by natural and recombinant immune interferon. Le J; Prensky W; Yip YK; Chang Z; Hoffman T; Stevenson HC; Balazs I; Sadlik JR; Vilcek J J Immunol; 1983 Dec; 131(6):2821-6. PubMed ID: 6417232 [TBL] [Abstract][Full Text] [Related]
26. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity. Khine AA; Lingwood CA J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of interferon-gamma by an interferon-gamma receptor immunoadhesin. Haak-Frendscho M; Marsters SA; Chamow SM; Peers DH; Simpson NJ; Ashkenazi A Immunology; 1993 Aug; 79(4):594-9. PubMed ID: 8406584 [TBL] [Abstract][Full Text] [Related]
28. Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages. Puddu P; Carollo MG; Belardelli F; Valenti P; Gessani S J Leukoc Biol; 2007 Aug; 82(2):347-53. PubMed ID: 17475783 [TBL] [Abstract][Full Text] [Related]
29. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Trottier MD; Palian BM; Reiss CS Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356 [TBL] [Abstract][Full Text] [Related]
30. [Action of human leukocyte and immune interferons on the reproduction and cytopathogenic effect of the encephalomyocarditis virus in mice]. Mentkevich LM; Zhdanova LV; Meshkova EN Vopr Virusol; 1984; 29(5):582-5. PubMed ID: 6097046 [TBL] [Abstract][Full Text] [Related]
31. Nitric oxide suppresses IFN-gamma production in the spleen of mercuric chloride-exposed brown Norway rats. van der Meide PH; de Labie MC; Botman CA; Aten J; Weening JJ Cell Immunol; 1995 Apr; 161(2):195-206. PubMed ID: 7697730 [TBL] [Abstract][Full Text] [Related]
32. [Patterns in the biosynthesis and action of human gamma-interferon]. Korobko IV; Kuznetsov VP; Malinovskaia VV; Frolova IS; Kushko IV Vopr Virusol; 1985; 30(3):350-4. PubMed ID: 2996243 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of anticellular activity of mouse gamma interferon by an inhibitor of interferon action. Fleischmann WR; Kirst CE; Fleischmann CM J Interferon Res; 1984; 4(2):193-200. PubMed ID: 6431018 [TBL] [Abstract][Full Text] [Related]
34. Potentiating effect of murine interferon-gamma-containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon-alpha/beta: identification of the potentiation factor as murine interferon-gamma itself. Fleischmann WR; Fleischmann CM Antiviral Res; 1984 Aug; 4(4):221-8. PubMed ID: 6091541 [TBL] [Abstract][Full Text] [Related]
35. Regulation of interferon-induced antiviral states: contrasting profiles of decay in response to the removal of MuIFN-alpha, MuIFN-beta and MuIFN-gamma. Ramamurthy V; Fleischmann WR J Gen Virol; 1986 Aug; 67 ( Pt 8)():1645-52. PubMed ID: 3016159 [TBL] [Abstract][Full Text] [Related]
36. [A macrophage migration-inhibiting factor in preparations of alpha- and gamma-interferon]. Vakhromeeva NS; Krylov OR; Kuznetsov VP; Medunitsyn NV; Bobkova EV Vopr Virusol; 1986; 31(1):86-9. PubMed ID: 3008442 [TBL] [Abstract][Full Text] [Related]
37. [Study of the antiviral action of a new low-molecular interferon inducer]. Shcherbakova EG; Furer NM; Rastunova GA; Litvinov AN; Zhigachev VE Antibiotiki; 1976 Sep; 21(9):838-42. PubMed ID: 187112 [No Abstract] [Full Text] [Related]
39. Type I and Type II interferon receptors. Orchansky P; Novick D; Fischer DG; Rubinstein M J Interferon Res; 1984; 4(2):275-82. PubMed ID: 6086780 [TBL] [Abstract][Full Text] [Related]
40. [Micromethod of human interferon titration]. Kondrat'eva GA; Ekimova ED; Iovlev VI; Cantell K Tr Inst Im Pastera; 1985; 62():132-6. PubMed ID: 3035755 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]